Ospemifene
2 NDCs across 1 manufacturer|0 Generic,2 Brand
Ospemifene is used to treat atrophy, dyspareunia and menopause, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Feb 26, 2013, and the first generic was approved Feb 13, 2024. In 2024, Medicare Part D spent $8 million on Ospemifene across 17,000 claims for 4,417 beneficiaries.
Ospemifene is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $8.17 to $8.17 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
1
competing in market
Price Spread
$8.17 – $8.17
per EA
7d Activity
avg -0.1% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Duchesnay USA, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Estrogen Agonist/Antagonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing OSPEMIFENE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
OSPHENA 60 MG TABLET | $8.1728 per EA | -0.06% |
OSPHENA 60 MG TABLET | $8.1728 per EA | -0.06% |
Frequently Asked Questions
What is Ospemifene used to treat?
Ospemifene is used to treat atrophy, dyspareunia and menopause, per the National Library of Medicine's MED-RT classification.
When did Ospemifene become available as a generic?
FDA approved the first generic Ospemifene (ANDA) on Feb 13, 2024.
How much does Medicare spend on Ospemifene?
In 2024, Medicare Part D spent $8 million on Ospemifene across 17,000 claims for 4,417 beneficiaries.
How many Ospemifene products are on the market?
The Ospemifene drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.
What is the price range for Ospemifene?
NADAC reference prices for Ospemifene range from $8.1728 to $8.1728 per EA.
Which manufacturers make Ospemifene?
1 manufacturer lists Ospemifene in NADAC. Ranked by number of NDCs, the largest are Duchesnay USA, Inc. (2).
How has the price of Ospemifene changed recently?
Over the past 7 days, 0 Ospemifene NDCs rose and 2 fell, with a market-wide average change of -0.1%.